Tianjin University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Tianjin China (1895)

Organization Overview

First Clinical Trial
2004
NCT01196260
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Sencond Affiliated Hospital of Tianjin University of Traditional Chinese Medicine | the chief of the neurology department, the First Hospital of Tianjin University of Chinese Traditional Medicine | Tianjin Center for Disease Control and Prevention | Tianjin Center for Diseases Control and Prevention | Tianjin Centers for Diseases Control and Prevention | Tianjin Haihe Hospital | Tianjin Hospital | Tianjin Union Medical Center | Tianjin University | Tian Jin university of tradtional chinese medicine

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angina Pectoris (Phase 3)

Angina, Stable (Phase 3)

Colorectal Neoplasms (Phase 3)

Coronavirus Infections (Phase 2)

Dementia (Phase 2)

Dementia, Vascular (Phase 2)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Pancreatitis (Phase 3)

Pneumonia (Phase 1)

Tuberculosis (Phase 4)

Tuberculosis, Pulmonary (Phase 4)

Virus Diseases (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 18
  • # of Trial APIs: 26